The cytokinome in osteoarthritis, a new paradigm in diagnosis and prognosis of cartilage disease


Article ID: 6609
Vol 30, Issue 4S1, 2016
DOI: https://doi.org/10.54517/jbrha6609
Received: 8 January 2017; Accepted: 8 January 2017; Available online: 8 January 2017; Issue release: 8 January 2017

Abstract

At present, diagnosis and progression monitoring of osteoarthritis (OA) is made through radiological and clinical assessment. Several studies investigated the role of synovial fluid analysis, to find out whether joint disease could be characterized by the pattern of cytokines, which acts during the pathogenic process or in specific stages of it. Online PubMed-Medline search was performed in order to retrieve evidence concerning synovial fluid analysis of cytokines involved in OA degenerative process. Concerning pro-inflammatory cytokines, it has been shown that interleukin (IL)-6, TNF-α and IL-17 are mainly over-expressed in the synovial fluid of OA joints, as well as anti-inflammatory cytokine IL-10. Variations of cytokines levels occur with radiological and clinical progression. It was also reported that metalloproteinases are involved. Synovial fluid analysis may be helpful in defining stage and type of OA, but more research is needed, especially focusing on the variation of sets of cytokines during OA stages and correlating these patterns with clinical features.


Keywords

osteoarthritis;cytokines;Synovial fluid;cytokinome;molecular signalling;cartilage disease


References

Supporting Agencies



Copyright (c) 2016




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).